Spero Therapeutics granted $15.7 million for research on SPR994, its oral carbapenem-class candidate, to study the drug’s efficacy against biological threats like anthrax, plague and melioidosis as a part of an interagency collaboration.
San Francisco based Verge Genomics, the Neuroscience based drug discovery company launched in 2015, has raised $32 million in early venture capital financing to bring its AI-generated compounds against Parkinson’s disease and amyotrophic lateral sclerosis (ALS) to clinics within the next three years.
A digital era in the medical field has arisen where one could find the increased utilization of health apps. But a recent analysis by a research team from the University of Sydney in Australia claims that these apps might lead to insignificant diagnosis and wrong information about the illness.
Viral hepatitis is a major global health issue since it is the seventh leading cause of death worldwide. Around half of hepatitis-related deaths reported are due to the hepatitis B virus infection, which is transmitted through blood and body fluids.
A systematic review revealed the inadequacy of adverse event data in clinical trials of probiotics and prebiotics, rendering it difficult to draw broad conclusions with regards to the safety of interventions to modify gut micro-organisms. These randomized trials assessed probiotics, prebiotics, or synbiotics, which are products that combine probiotics and probiotics.
The Office of the National Coordinator for Health IT which introduced The Certified Health IT Product List Data Challenge in the last week, has initiated a contest for innovative ideas that highlights how its vast and meticulous specs can enhance service to hospitals and health systems.
The CQC rated the South Doc Services Limited as ‘outstanding’ in a report on 11 July. The service operates virtual primary care services for the MyHealthcare GP federation, functioning at several hubs across Birmingham with more than 47 GP practices under its umbrella catering to around 300,000 registered patients. The report praised how the “service used technology to improve treatment and to support patients’ independence”.
A scientists team from the University of Sheffield have discovered that the human pathogen named Staphylococcus aureus especially MRSA (Methicillin-Resistant Staphylococcus aureus) uses non-threatening bacteria in the skin to initiate infection.
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.